NCS Multistage to Acquire ResMetrics, Further Expanding Tracer Diagnostics Offering
MWN-AI** Summary
On July 31, 2025, NCS Multistage Holdings, Inc. (NASDAQ:NCSM) announced the acquisition of ResMetrics LLC, a premier provider of chemical tracer diagnostics services tailored for the oil and gas sector. This strategic move aims to augment NCS's existing tracer diagnostics capabilities, enabling oil and gas operators to refine reservoir development strategies, enhance hydraulic fracture stimulation designs, assess inter-well connectivity, and optimize enhanced oil recovery initiatives.
Ryan Hummer, CEO of NCS Multistage, expressed enthusiasm about the acquisition, highlighting the synergistic potential of ResMetrics’ esteemed chemical tracer technologies to empower customers in maximizing well performance and financial returns. Sharad Behal, CEO of ResMetrics, echoed this sentiment, noting that the merger would spur growth and broaden the diagnostic solutions available to clients.
ResMetrics, founded in partnership with CSL Capital Management, has earned a strong reputation for delivering reliable tracer diagnostics. Charlie Leykum, CEO of CSL, praised ResMetrics for its commitment to advancing tracer technologies and recognized the significant value this integration with NCS would bring to customers.
As a leading provider of engineering products and services aimed at optimizing oil and gas well construction and development, NCS Multistage operates in numerous regions including North America, the North Sea, and parts of the Middle East. The company has stated that it will offer further insight into the acquisition during its second-quarter earnings call on August 1, 2025.
ResMetrics is distinguished for its robust quality control systems and cutting-edge analytical labs, delivering critical data to support completion designs and reservoir optimization, with operations spanning the U.S., UAE, and Kuwait. The merger is expected to solidify NCS’s position within the industry while enhancing its service offerings.
MWN-AI** Analysis
As NCS Multistage Holdings, Inc. (NASDAQ: NCSM) embarks on its acquisition of ResMetrics LLC, the market may respond positively to this strategic move. The integration of ResMetrics’ suite of chemical tracer diagnostics will enhance NCS’s existing capabilities, addressing the growing demand for sophisticated reservoir management and optimization solutions in the oil and gas sector. By augmenting its tracer diagnostics offerings, NCS positions itself to deliver even more comprehensive services to its clients, improving well performance and ultimately maximizing financial returns.
Investors should observe that the acquisition is not merely a vertical integration but also a way to tap into ResMetrics’ established client base and reputation for quality—elements that could accelerate revenue growth for NCS. Furthermore, with ResMetrics's specialization in high-temperature applications and enhanced oil recovery, this merger aligns with industry trends towards more efficient and innovative extraction techniques.
Given the cyclical nature of oil and gas markets, the strategic alignment with ResMetrics enables NCS to diversify its service offerings, potentially insulating the company from volatility associated with crude price fluctuations. The increasing global energy demand underscores the relevance of advanced technologies in optimizing resource extraction, positioning NCS favorably for long-term growth.
As NCS prepares to disclose additional details during the upcoming earnings conference call, analysts and investors should monitor any insights into projected synergies, integration timeframes, and specific financial impacts from this acquisition.
For current shareholders and potential investors, maintaining a close eye on NCS’s stock price movement and performance metrics will be essential in gauging market sentiment following this acquisition. Overall, this announcement underscores NCS’s commitment to innovation in the oilfield sector, presenting a compelling case for investment considering favorable industry dynamics and enhanced service capabilities.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (NASDAQ:NCSM) (“NCS” or the “Company”) today announced that it has acquired ResMetrics LLC (“ResMetrics”), a leading provider of chemical tracer diagnostics services used by oil and gas operators to validate reservoir development strategies, improve hydraulic fracture stimulation designs, evaluate inter-well connectivity, and optimize enhanced oil recovery injection programs, complementing and further strengthening NCS’s tracer diagnostics capabilities.
“I am excited to welcome the ResMetrics team to NCS,” said Ryan Hummer, NCS’s Chief Executive Officer. “ResMetrics brings trusted chemical tracer technologies that complement our existing capabilities, enhancing our ability to deliver actionable insights that help customers maximize well performance and financial returns.”
“ResMetrics has built a strong reputation for delivering high quality and reliable tracer diagnostics services to our customers,” said Sharad Behal, Chief Executive Officer of ResMetrics. “We expect that joining together with NCS will accelerate our growth and increase the breadth of diagnostics and other solutions available to our customers.”
ResMetrics was built in conjunction with CSL Capital Management. Charlie Leykum, Founding Partner and CEO of CSL, expressed his admiration for the achievements of the ResMetrics team, stating, “I am incredibly proud of the dedication and innovation demonstrated by ResMetrics since its founding. Their commitment to advancing tracer diagnostics and delivering value to customers has solidified their leadership position in the industry. We are excited to see ResMetrics enter this next chapter with NCS and look forward to all that the future holds for the company and its talented team.”
Shook, Hardy and Bacon L.L.P. served as legal advisor to NCS. Piper Sandler acted as exclusive financial advisor and Winston Strawn LLP served as legal advisor to ResMetrics.
NCS will provide additional details on the ResMetrics acquisition during its second quarter earnings conference call scheduled for August 1, 2025.
NCS Multistage Holdings, Inc. is a leading provider of highly engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides products and services primarily to exploration and production companies for use in onshore and offshore wells, predominantly wells that have been drilled with horizontal laterals in both unconventional and conventional oil and natural gas formations. NCS’s products and services are utilized in oil and natural gas basins throughout North America and in selected international markets, including the North Sea, the Middle East, Argentina and China. NCS’s common stock is traded on the Nasdaq Capital Market under the symbol “NCSM.” Additional information is available on the website, www.ncsmultistage.com .
ResMetrics, LLC is a leading provider of oilfield tracer services, leveraging robust quality control systems and its state-of-the-art analytical laboratory to ensure accurate results. ResMetrics provides its customers with valuable data to assess and improve completion designs and to efficiently optimize reservoir development and production, including in enhanced oil recovery and high-temperature applications. ResMetrics provides its services primarily in the United States, the UAE and Kuwait.
Contact:
Mike Morrison
Chief Financial Officer and Treasurer
+1 281-453-2222
IR@ncsmultistage.com
FAQ**
How does the acquisition of ResMetrics by NCS Multistage Holdings Inc. (NCSM) enhance its existing chemical tracer diagnostics capabilities in the oil and gas sector?
What specific benefits can clients of NCS Multistage Holdings Inc. (NCSM) expect from ResMetrics' trusted chemical tracer technologies?
In which geographical markets does NCS Multistage Holdings Inc. (NCSM) plan to expand its tracer diagnostics services following the acquisition of ResMetrics?
How will the integration of ResMetrics' services into NCS Multistage Holdings Inc. (NCSM) impact their financial performance and growth strategy moving forward?
**MWN-AI FAQ is based on asking OpenAI questions about NCS Multistage Holdings Inc. (NASDAQ: NCSM).
NASDAQ: NCSM
NCSM Trading
8.71% G/L:
$60.01 Last:
37,437 Volume:
$54.55 Open:
